Karmanos Cancer Institute / Wayne State University — Detroit, Michigan

Karmanos Cancer Institute / Wayne State University is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute / Wayne State University has participated in 20 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Disease, Hodgkin.

Sponsors: Seagen Inc., Karyopharm Therapeutics Inc, Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute / Wayne State University?

Karmanos Cancer Institute / Wayne State University has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute / Wayne State University conducted?

Karmanos Cancer Institute / Wayne State University has 20 clinical trials on record. Their work covers Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Disease, Hodgkin.

Is Karmanos Cancer Institute / Wayne State University accredited by Crixeo Health?

Yes — Karmanos Cancer Institute / Wayne State University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Karmanos Cancer Institute / Wayne State University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.